Phenotype of Headache and Facial Pain in Upper Respiratory Tract Infections
NCT ID: NCT06127186
Last Updated: 2024-04-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
223 participants
OBSERVATIONAL
2023-11-01
2024-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. What is the phenotype of headache / facial pain in URTIs
2. Does the above mentioned phenotype is associated with:
1. aetiologic factor (virus),
2. type of URTI
3. headache/facial pain experienced by patients in the past.
Participants will:
* answer standardized questions,
* undergo physical examination,
* have a swab test performend for antigens of common viruses causing URTI.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Phenotype and Burden of a Midfacial Segment Pain
NCT06299995
A Study of the Effect of Rhythmic Sensory Stimulation on Fibromyalgia
NCT02493348
Evaluation and Diagnosis of People With Pain and Fatigue Syndromes
NCT00677157
A Study for Adolescents With Fibromyalgia Syndrome
NCT01089621
Hyperthermia in Fibromyalgia Syndrome
NCT05135936
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group
Patients reporting for primary care assessment because of URTI.
Swab test for viral antigens
No intervention except for a routine examination and viral testing is planned.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Swab test for viral antigens
No intervention except for a routine examination and viral testing is planned.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed consent to participate in the study
Exclusion Criteria
* neoplasms
* signs or symptoms of a serious neurologic or psychiatric disorder.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Marcin Straburzynski
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marcin Straburzynski
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Marcin Straburzyński
Dźwierzuty, Warmian-Masurian Voivodeship, Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
URTI HA FP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.